Skip to main content
. Author manuscript; available in PMC: 2021 May 22.
Published in final edited form as: Vaccine. 2020 Apr 27;38(25):4125–4134. doi: 10.1016/j.vaccine.2020.03.052

Table 5.

Multivariate Associations – Perceived Risks by Daughter’s Dose of HPV Vaccination at follow-up*

Completed 1st HPV Vaccination Dose Complete 2nd HPV Vaccination Dose Completed 3rd HPV Vaccination Dose

Unadjusteda OR 95% CI OR 95% CI OR 95% CI
HPV vs. Control 5.96 3.38 10.49 8.09 4.0 16.35 16.5 5.73 47.48
Perceived risk for cervical cancer
Yes vs. No 1.85 0.94 3.65 2.28 1.04 4.96 1.64 0.69 3.88
DK/NS vs. No 1.32 0.68 2.56 1.51 0.69 3.3 1.38 0.59 3.23
Worry about getting infected with HPV
Yes vs. No 0.85 0.46 1.58 1.14 0.57 2.3 1.02 0.47 2.23
DK/NS vs. No 0.7 0.27 1.8 0.65 0.21 2.03 0.7 0.2 2.44
Perceived risk for HPV infection
Yes vs. No 1.26 0.6 2.61 1.0 0.44 2.28 0.56 0.2 1.56
DK/NS vs. No 0.71 0.41 1.23 0.77 0.42 1.41 0.64 0.33 1.27
Worry daughter would be infected with HPV in future
Yes vs. No 1.46 0.38 5.63 0.92 0.24 3.58 1.05 0.22 5.02
DK/NS vs. No 0.7 0.14 3.45 0.2 0.03 1.4 0.16 0.01 1.99
Perceived risk for daughter’s HPV infection in future
Yes vs. No 0.81 0.31 2.09 0.47 0.18 1.24 0.41 0.15 1.12
DK/NS vs. No 0.61 0.22 1.66 0.36 0.13 1.03 0.24 0.08 0.75
Adjustedb
Intervention (HPV) vs. Control 5.96 3.32 10.72 7.52 3.62 15.62 15.82 5.26 47.6
Perceived risk for cervical cancer
Yes vs. No 1.25 0.53 2.93
DK/NS vs. No 1.03 0.44 2.44
Perceived risk for daughter’s HPV infection in future
Yes vs. No 0.69 0.23 2.1
DK/NS vs. No 0.76 0.2 2.82
*

N=259 participants at follow-up. Intent to treat HPV arm=126, control arm=133.

a

Unadjusted statistically significant (p<0.05) OR in bold.

b

OR adjusted by mother’s age, time in US, income, and daughter’s health insurance status. No demographic significant. Significant HPV predictors only shown in adjusted multivariate logistic models.